From: Network meta-analysis of invasive treatment for early-stage osteonecrosis of the femoral head
 |  | CD | 6.27 (− 5.21, 17.98) | 11.61 (− 3.36, 26.80) | 3.83 (− 6.02, 13.67) | 8.74 (2.36, 15.25) | 7.07 (− 7.76, 21.56) | HHS Score |
 | CD |  | BG | 5.38 (− 13.63, 24.29) |  − 2.44 (− 14.05, 9.03) | 2.48 (− 10.07, 15.05) | 0.77 (− 17.97, 19.23) |  |
 | 2.16 (0.39, 13.13) | BG |  | CD + PRP |  − 7.83 (− 25.87, 10.18) |  − 2.88 (− 19.16, 13.41) |  − 4.57 (− 25.77, 16.39) |  |
 | 3.59 (0.69, 29.66) | 1.69 (0.14, 24.83) | CD + PRP |  | CD + BG | 4.91 (− 5.27, 15.21) | 3.27 (− 14.57, 20.83) |  |
 | 3.3 (1.08, 10.65) | 1.51 (0.29, 8.07) | 0.91 (0.09, 7.05) | CD + BG |  | CD + BMMSC |  − 1.66 (− 17.90, 14.14) |  |
 | 10.13 (1.14, 116.98) | 4.68 (0.38, 71.25) | 2.77 (0.14, 54.07) | 3 (0.48, 26.84) | CD + BG + BMMSC |  | CD + SAI |  |
Clinical Failure Rate | 2.92 (1.58, 5.61) | 1.36 (0.21, 8.14) | 0.81 (0.09, 4.84) | 0.88 (0.26, 2.92) | 0.29 (0.02, 2.68) | CD + BMMSC |  |  |